# 4 Crucial Thyroid Eye Disease Questions Every Woman Must Ask
If you’ve recently been diagnosed with hyperthyroidism or Graves’ disease, you may have noticed changes in your eyes that feel confusing, uncomfortable, or even alarming. That persistent gritty sensation, the feeling of pressure behind your eyes, or a subtle change in your appearance may not be “just a side effect” of your thyroid condition. It could be something far more specific: Thyroid Eye Disease.
As a clinician, I’ve seen far too many women dismiss early symptoms of TED as fatigue or allergies. The reality is that Thyroid Eye Disease (TED) affects approximately one in three women with Graves’ disease, and early intervention is everything. This guide is designed to empower you with four essential questions to ask your healthcare provider—because when you know what to ask, you take control of your care.
## What Is Thyroid Eye Disease? A Quick Foundation
Before we dive into the questions, let’s clarify what TED actually is. This is not simply “dry eyes from medication.” Thyroid Eye Disease is an autoimmune condition where your body’s immune system mistakenly attacks the tissues and muscles behind and around your eyes. This attack triggers inflammation, leading to swelling, tissue expansion, and sometimes scarring.
TED can occur even if your thyroid hormone levels are normal, and it often runs a distinct course: an active (inflammatory) phase that can last 6 to 24 months, followed by a stable (chronic) phase. Knowing which phase you’re in changes everything about your treatment strategy.
## Question #1: “Am I Currently in the Active or Inactive Phase?”
This is the single most important question you can ask. The answer determines whether you need aggressive medical intervention or can focus on symptom management and monitoring.
Signs of the active phase include:
- Redness or pinkness of the eyelid margins
- Noticeable swelling of the eyelids or tissues around the eye
- Progressive bulging (proptosis) of one or both eyes
- Pain or a deep pressure sensation when moving the eyes
- Double vision that comes and goes, especially when looking in certain directions
If you are in the active phase, your doctor may recommend anti-inflammatory treatments, such as high-dose selenium supplements, oral corticosteroids, or new FDA-approved biologic therapies like teprotumumab (Tepezza). These treatments can significantly shorten the active phase and reduce long-term damage.
If you are in the inactive phase, surgery—such as orbital decompression or eyelid repositioning—becomes the primary option to address functional problems like double vision or cosmetic concerns. Never let a doctor tell you “just wait and see” without first confirming your phase.
## Question #2: “Do I Have Risk Factors That May Worsen My Disease?”
Certain lifestyle and health factors act as fuel for the autoimmune fire in TED. As a woman, you may face specific triggers that men do not experience as frequently.
Key risk factors to discuss:
- Smoking or vaping: This is non-negotiable. Women who smoke with Graves’ disease develop TED up to eight times more often than non-smokers. Even secondhand smoke exposure can worsen inflammation.
- Radioactive iodine (RAI) treatment: While effective for hyperthyroidism, RAI can trigger or accelerate TED in susceptible women. If you’ve had RAI within the last six months, your eye symptoms may be directly linked to that treatment.
- Unstable thyroid levels: Swinging between hyperthyroid and hypothyroid states (or having a TSH that is suppressed) can provoke eye inflammation. Consistent thyroid management is non-negotiable.
- Pregnancy and postpartum hormonal shifts: Many women report TED onset or worsening after childbirth due to immune system changes. If you are considering pregnancy, have your ophthalmologist involved in your preconception planning.
If you cannot stop smoking, ask about nicotine replacement therapy. If you’ve had RAI, discuss whether your eye symptoms need a rheumatologist or oculoplastic surgeon early in the process. Do not assume these factors are minor; they are the difference between a mild case and a severe, disfiguring one.
## Question #3: “What Is My Current Visual Function Score?”
Many women focus on how their eyes look, but function matters far more for long-term quality of life. Bulging eyes can be surgically corrected later, but damage to the optic nerve or persistent double vision can be permanent.
Specific assessments your doctor should perform:
- Visual acuity (sharpness): If your vision is blurry or has changed, it may indicate optic nerve compression—a medical emergency.
- Color vision test: Reduced ability to see red or green hues is an early sign of optic nerve involvement.
- Exophthalmometry measurement: This device measures how far your eyes protrude. A change of 2 mm or more over three months is significant.
- Binocular single vision testing: This checks for double vision (diplopia) in different gaze positions. If double vision is present when you look straight ahead, you may require prism glasses or surgery.
Ask for a written record of these measurements. TED progression is often slow, and having baseline numbers allows you to track changes objectively. If your doctor doesn’t have an exophthalmometer, consider finding a specialist who does—this is a standard tool in TED care, not a luxury.
## Question #4: “Which Treatments Are Appropriate for My Phase and Severity?”
Treatment for TED is not one-size-fits-all. Many women are given artificial tears and told to wait, which can allow permanent structural damage to occur. You deserve a personalized treatment roadmap.
Medical management (active phase):
- Selenium supplementation: 200 mcg daily has been shown to slow progression in mild cases.
- Corticosteroids (oral or intravenous): IV steroids are more effective than oral and have fewer systemic side effects.
- Teprotumumab (Tepezza): This biologic therapy directly targets the immune cells attacking your orbital tissues. It is the first FDA-approved drug for TED and can reduce proptosis, double vision, and inflammation without surgery.
Surgical options (stable/inactive phase):
- Orbital decompression: Removes bone and fat behind the eye to allow the eye to settle back into the socket.
- Strabismus surgery: Realigns the eye muscles to correct double vision.
- Eyelid surgery: Addresses retracted eyelids or redundant skin.
Supportive care for any phase:
- Preservative-free lubricating drops and gels (avoid drops with redness reducers like tetrahydrozoline)
- Elevating the head of your bed to reduce morning swelling
- Cold compresses for acute inflammation
- Prism glasses for temporary double vision relief
Ask specifically: “Given my phase, clinical measurements, and risk factors, what is the first-line treatment we should try? What is the second-line option if that fails?” A good clinician will have a clear answer, not a vague plan.
## A Final Word for Every Woman Reading This
Thyroid Eye Disease can feel isolating. It changes how you see the world and how the world sees you. But you are not alone, and you do not have to accept uncertainty as part of your care. Armed with these four questions, you can walk into your next appointment as an informed advocate for your eyes.
Write these questions down. Bring a notebook. If your provider hesitates or gives vague answers, seek a second opinion—preferably from an oculoplastic surgeon or a neuro-ophthalmologist who specializes in TED. Your eyes are not a “wait and see” problem. They are a treatable condition, and the earlier you ask the right questions, the better your visual and cosmetic outcomes will be.
